With the confidence and "information" that was shown in the webinar yesterday this should be much higher even before approval.
It seems that revenue will start flowing very quickly! I am so impressed with the marketing strategy, patient/practitioner support and platforms to facilitate the very quick uptake of Sofdra!
It's nearly like the board is waiting for FDA approval so that they can showcase the platforms not just the drug!
Imagine if the IT platforms really take off and become a marketing/supply strategy for for other pharmaceuticals - either our own or other companies!
With the confidence and "information" that was shown in the...
-
- There are more pages in this discussion • 1,967 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $751.1M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 43.0¢ | 40.5¢ | $3.179M | 7.658M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 83000 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 367540 | 8 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |